These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 7923115

  • 1. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck.
    Zhang SY, Klein-Szanto AJ, Sauter ER, Shafarenko M, Mitsunaga S, Nobori T, Carson DA, Ridge JA, Goodrow TL.
    Cancer Res; 1994 Oct 01; 54(19):5050-3. PubMed ID: 7923115
    [Abstract] [Full Text] [Related]

  • 2. Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV.
    Olshan AF, Weissler MC, Pei H, Conway K, Anderson S, Fried DB, Yarbrough WG.
    Oncogene; 1997 Feb 20; 14(7):811-8. PubMed ID: 9047388
    [Abstract] [Full Text] [Related]

  • 3. Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas.
    Huang L, Goodrow TL, Zhang SY, Klein-Szanto AJ, Chang H, Ruggeri BA.
    Cancer Res; 1996 Mar 01; 56(5):1137-41. PubMed ID: 8640773
    [Abstract] [Full Text] [Related]

  • 4. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma.
    Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J, Sidransky D.
    Cancer Res; 1996 Aug 15; 56(16):3630-3. PubMed ID: 8705996
    [Abstract] [Full Text] [Related]

  • 5. Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells.
    Brenner AJ, Aldaz CM.
    Cancer Res; 1995 Jul 01; 55(13):2892-5. PubMed ID: 7796417
    [Abstract] [Full Text] [Related]

  • 6. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
    Okami K, Reed AL, Cairns P, Koch WM, Westra WH, Wehage S, Jen J, Sidransky D.
    Oncogene; 1999 Jun 10; 18(23):3541-5. PubMed ID: 10376532
    [Abstract] [Full Text] [Related]

  • 7. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
    Wiest JS, Franklin WA, Otstot JT, Forbey K, Varella-Garcia M, Rao K, Drabkin H, Gemmill R, Ahrent S, Sidransky D, Saccomanno G, Fountain JW, Anderson MW.
    Cancer Res; 1997 Jan 01; 57(1):1-6. PubMed ID: 8988029
    [Abstract] [Full Text] [Related]

  • 8. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A, Gaddipati JP, Moul JW, Srivastava S.
    J Urol; 1998 May 01; 159(5):1725-30. PubMed ID: 9554401
    [Abstract] [Full Text] [Related]

  • 9. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma.
    Kim SK, Fan Y, Papadimitrakopoulou V, Clayman G, Hittelman WN, Hong WK, Lotan R, Mao L.
    Cancer Res; 1996 Jun 01; 56(11):2519-21. PubMed ID: 8653689
    [Abstract] [Full Text] [Related]

  • 10. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A, Bellmann U, Bootz F, Wittekind C, Tannapfel A.
    Virchows Arch; 2002 Aug 01; 441(2):133-42. PubMed ID: 12189502
    [Abstract] [Full Text] [Related]

  • 11. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis.
    Toomes C, Jackson A, Maguire K, Wood J, Gollin S, Ishwad C, Paterson I, Prime S, Parkinson K, Bell S, Woods G, Markham A, Oliver R, Woodward R, Sloan P, Dixon M, Read A, Thakker N.
    Genes Chromosomes Cancer; 2003 Jun 01; 37(2):132-40. PubMed ID: 12696061
    [Abstract] [Full Text] [Related]

  • 12. Abrogation of the p16-retinoblastoma-cyclin D1 pathway in head and neck squamous cell carcinomas.
    Park HW, Song SY, Lee TJ, Jeong D, Lee TY.
    Oncol Rep; 2007 Jul 01; 18(1):267-72. PubMed ID: 17549378
    [Abstract] [Full Text] [Related]

  • 13. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.
    González MV, Pello MF, López-Larrea C, Suárez C, Menéndez MJ, Coto E.
    Clin Cancer Res; 1995 Sep 01; 1(9):1043-9. PubMed ID: 9816078
    [Abstract] [Full Text] [Related]

  • 14. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
    Packenham JP, Taylor JA, White CM, Anna CH, Barrett JC, Devereux TR.
    Clin Cancer Res; 1995 Jul 01; 1(7):687-90. PubMed ID: 9816033
    [Abstract] [Full Text] [Related]

  • 15. Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract.
    Igaki H, Sasaki H, Tachimori Y, Kato H, Watanabe H, Kimura T, Harada Y, Sugimura T, Terada M.
    Cancer Res; 1995 Aug 01; 55(15):3421-3. PubMed ID: 7614482
    [Abstract] [Full Text] [Related]

  • 16. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS.
    Arch Otolaryngol Head Neck Surg; 2006 Apr 01; 132(4):409-15. PubMed ID: 16618910
    [Abstract] [Full Text] [Related]

  • 17. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
    Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN.
    Cancer Res; 1996 Jan 01; 56(1):150-3. PubMed ID: 8548755
    [Abstract] [Full Text] [Related]

  • 18. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.
    Pollock PM, Pearson JV, Hayward NK.
    Genes Chromosomes Cancer; 1996 Feb 01; 15(2):77-88. PubMed ID: 8834170
    [Abstract] [Full Text] [Related]

  • 19. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma.
    Yarbrough WG.
    Laryngoscope; 2002 Dec 01; 112(12):2114-28. PubMed ID: 12461329
    [Abstract] [Full Text] [Related]

  • 20. The MTS1 gene is frequently mutated in primary human esophageal tumors.
    Zhou X, Tarmin L, Yin J, Jiang HY, Suzuki H, Rhyu MG, Abraham JM, Meltzer SJ.
    Oncogene; 1994 Dec 01; 9(12):3737-41. PubMed ID: 7970734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.